These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5988529)

  • 1. [Therapeutic actions of Pyridofylline in dyspnea, hyperlipemia and certain hepatobiliary diseases].
    Quinton A
    Sem Ther; 1966 Nov; 42(9):532-5. PubMed ID: 5988529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Eupneizing and pyridoxine-like action of a new synthetic compound: Pyridofylline].
    Despierres G; Cotte J; Dutruge ; Falconnet
    J Med Lyon; 1966 Mar; 47(94):383-93. PubMed ID: 5909921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of an hepatobiliary analeptic agent].
    Chapuy H; Jeune M; Sambin P; Girard M
    J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
    [No Abstract]   [Full Text] [Related]  

  • 4. [The liver, hepatobiliary infections and antibiotics].
    Brogard JM; Vetter D
    Gastroenterol Clin Biol; 1989 Jan; 13(1):51-3. PubMed ID: 2925043
    [No Abstract]   [Full Text] [Related]  

  • 5. [New therapeutic approaches in biliary tract and liver diseases].
    Ernst W
    Ther Ggw; 1966 Jan; 105(1):116-23. PubMed ID: 5914083
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotics and hepatobiliary diseases].
    Metreau JM; Berthelot P
    Therapie; 1974; 29(3):369-75. PubMed ID: 4439356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV; Lebedeva OI
    Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Galstena therapy of some hepatobiliary diseases].
    Munushkin ON
    Klin Med (Mosk); 2001; 79(12):38-41. PubMed ID: 11840810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of antioxidants in patients with chronic diseases of the hepatobiliary system (a review of the literature)].
    Epishin AV; Rudiak GI
    Vrach Delo; 1990 Apr; (4):24-7. PubMed ID: 2275156
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapeutic use of a phosphatide food concentrate in diseases of the hepatobiliary system].
    Mel'nichenko LIa; Sheleketina II; Averianova LP; Iagmur SS
    Lik Sprava; 1997; (6):53-6. PubMed ID: 9589927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observations on the use of a phosphatidylcholine-based preparation in patients with hepatobiliary diseases of surgical significance].
    Battistini C; Lampugnani R
    Minerva Dietol Gastroenterol; 1977; 23(3):219-36. PubMed ID: 618097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Infectious hepatobiliary diseases].
    Kunii O
    Naika; 1972; 29(2):215-21. PubMed ID: 4552440
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new antidyspeptic in hepato-biliary disorders].
    Copelman H
    Hospital (Rio J); 1969 Apr; 75(4):1463-8. PubMed ID: 5306436
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of injectable ampicillin in hepato-biliary diseases in particular].
    Fraisse H; Etaix JP
    Lyon Med; 1966 Jan; 215(5):271-7. PubMed ID: 5909728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of the umbilical vein in the treatment of several liver and biliary tract diseases].
    Tsykhivshvili NA; Gal'perin EI; Podol'skiĭ AE
    Khirurgiia (Mosk); 1971 Jul; 47(7):102-9. PubMed ID: 5118891
    [No Abstract]   [Full Text] [Related]  

  • 18. Does theophylline improve dyspnea in nonreversible COPD?
    Cohen BM
    N J Med; 1986 Apr; 83(4):227-31. PubMed ID: 3459061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
    Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa
    Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hepato-biliary diseases in children and adults by a drug composed of orotic acid and sorbitol].
    Cachin M; Alagille D
    Presse Med (1893); 1967 Apr; 75(17):859-60. PubMed ID: 6021371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.